SCHEMBL29469607

SCHEMBL29469607

Cc1ccc(S(=O)(=O)NC(=O)c2cc3c(F)cc(N4CCC4)cc3o2)c2ccccc12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 8/20 0.41
MAPT P10636 7/20 0.41
MEN1 O00255 5/20 0.41
ALDH1A1 P00352 4/20 0.41
MAPK1 P28482 1/20 0.41
ATM Q13315 1/20 0.41
POLB P06746 3/20 0.40
KDM4E B2RXH2 3/20 0.40
GAA P10253 3/20 0.40
HPGD P15428 3/20 0.40
GLA P06280 1/20 0.40
RXFP1 Q9HBX9 1/20 0.36
MCL1 Q07820 2/20 0.36
NPC1 O15118 2/20 0.36
RAB9A P51151 2/20 0.36
LMNA P02545 4/20 0.35
TP53 P04637 2/20 0.35
BLM P54132 1/20 0.35
HTR2B P41595 1/20 0.34
HTR6 P50406 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24333973 1.00 KMT2A (0.41) KMT2AMAPTMEN1ALDH1A1MAPK1
SCHEMBL29469632 0.90 KMT2A (0.38) KMT2AMAPTMEN1ALDH1A1MAPK1
SCHEMBL24333674 0.90 KMT2A (0.38) KMT2AMAPTMEN1ALDH1A1MAPK1
SCHEMBL24333768 0.89 MAPT (0.34) KMT2AMAPTMEN1ALDH1A1MAPK1
SCHEMBL24334452 0.88 CCR8 (0.37) KMT2AMAPTMEN1ALDH1A1MAPK1
SCHEMBL31525463 0.85 KAT6A (0.41) KMT2AMAPTALDH1A1MAPK1GAA
SCHEMBL29469686 0.85 NLRP3 (0.44) KMT2AATM
SCHEMBL24334396 0.85 FABP4 (0.38) MAPTALDH1A1MAPK1GAAHPGD
SCHEMBL24334273 0.85 NLRP3 (0.44) KMT2AATM
SCHEMBL29469709 0.85 FABP4 (0.38) MAPTALDH1A1MAPK1GAAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4229048-A1 SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER The Broad Institute, Inc. (US) 2023-08-23 EP claimed
WO-2022081807-A1 SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER THE BROAD INSTITUTE, INC. (US) 2022-04-21 WO claimed
EP-4229048-A1 SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER The Broad Institute, Inc. (US) 2023-08-23 EP disclosed
WO-2022081807-A1 SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER THE BROAD INSTITUTE, INC. (US) 2022-04-21 WO disclosed